Myomo, Inc.

$ 1.28 -9.86 %

Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.

CEO: Paul R. Gudonis - https://www.myomo.com

Price objectif

$1.1 -14.06 %

Recommandation

Buy

DCF

$ -22.55

Loading data...

MYO vs S&P500

Loading data...

No data available.

Quick ratio

2.36

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

-3.56

may indicate that the company is undervalued or has poor growth prospects.

EPS

-0.36

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

-114.87 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

-50.20 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

9.44

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

2.11

means it relies more on debt, which can increase financial risk.

Free cash flow per share

-0.41

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
3 indicates worrying financial health
Altman score
-3.11 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
1.21 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.52 indicates a moderate level of debt, which is generally acceptable but may present some risk
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.